Literature DB >> 8940439

Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995.

B Lina1, M Valette, S Foray, J Luciani, J Stagnara, D M See, M Aymard.   

Abstract

Nasal swab from patients with acute flu-like illness were evaluated for the presence of respiratory viruses in the Rhone-Alpes region of France from 1 October 1994 through 2 May 1995. The relative frequencies and seasonal distributions of the specific viruses were assessed. In addition, virus type was correlated with specific clinical signs and symptoms. During the study, 962 samples were collected by 75 medical practitioners participating in the Groupe Regional d'Observation de la Grippe surveillance network. One or more viruses were detected from 348 samples (36.1%), including 108 respiratory syncytial virus (RSV), 64 influenza virus A type H3N2, 47 influenza virus B, 64 coronavirus, 35 rhinovirus, 22 adenovirus, 5 enterovirus, and 3 parainfluenza-fluenza strains. There were 16 mixed infections. RSV infections peaked in the early winter, and influenza viruses A and B infections peaked during the late winter and early spring. There were two peaks of coronavirus infections (late fall and late winter). Other viruses were detected at lower levels throughout the study period. Patients from whom adenovirus was isolated were significantly more likely to have a fever of > 39.5 degrees C than were patients with other detectable viruses (P < 0.001). Furthermore, there was a significant correlation between influenza and cough (P < 0.01) and RSV and bronchiolitis (P < .001). Thus, the current study defined the overall and relative frequencies of respiratory virus detection from nasal swab specimens in patients with an acute flu-like illness in the Rhone-Alpes region of France during a 7-month period. Correlation with clinical signs and symptoms and provisional conclusions regarding seasonality were also determined.

Entities:  

Mesh:

Year:  1996        PMID: 8940439      PMCID: PMC229450          DOI: 10.1128/jcm.34.12.3007-3011.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

Review 1.  Global surveillance of influenza.

Authors:  M S Pereira
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

Review 2.  Epidemiology of influenza in man.

Authors:  C Stuart-Harris
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

3.  Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses.

Authors:  J L Melnick; V Rennick; B Hampil; N J Schmidt; H H Ho
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  Europe preparing to face an influenza pandemic.

Authors:  C Hannoun
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

5.  Monoclonal antibodies against respiratory syncytial virus and their use for rapid detection of virus in nasopharyngeal secretions.

Authors:  P Pothier; J C Nicolas; G P de Saint Maur; S Ghim; A Kazmierczak; F Bricout
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity.

Authors:  J R Panuska; R Merolla; N A Rebert; S P Hoffmann; P Tsivitse; N M Cirino; R H Silverman; J A Rankin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  The prediction of epidemics of respiratory infection.

Authors:  D M Fleming
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

8.  Surveillance of respiratory viruses. A 10-year laboratory-based study.

Authors:  J M McAnerney; S Johnson; B D Schoub
Journal:  S Afr Med J       Date:  1994-08

9.  Rhinoviruses in Seattle families, 1975-1979.

Authors:  J P Fox; M K Cooney; C E Hall; H M Foy
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

10.  Diagnosis of human coronavirus infection by immunofluorescence: method and application to respiratory disease in hospitalized children.

Authors:  K McIntosh; J McQuillin; S E Reed; P S Gardner
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

View more
  47 in total

1.  Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season.

Authors:  K Loens; H Goossens; C de Laat; H Foolen; P Oudshoorn; S Pattyn; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 2.  OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.

Authors:  Urs B Schaad
Journal:  World J Pediatr       Date:  2010-02-09       Impact factor: 2.764

3.  Respiratory viral infections among pediatric inpatients and outpatients in Taiwan from 1997 to 1999.

Authors:  H P Tsai; P H Kuo; C C Liu; J R Wang
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece.

Authors:  M N Tsolia; D Kafetzis; K Danelatou; H Astral; K Kallergi; P Spyridis; Th E Karpathios
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses.

Authors:  J Stockton; J S Ellis; M Saville; J P Clewley; M C Zambon
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice.

Authors:  L J van Elden; G A van Essen; C A Boucher; A M van Loon; M Nijhuis; P Schipper; T J Verheij; I M Hoepelman
Journal:  Br J Gen Pract       Date:  2001-08       Impact factor: 5.386

7.  Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods.

Authors:  M P Layani-Milon; I Gras; M Valette; J Luciani; J Stagnara; M Aymard; B Lina
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Human metapneumovirus infection in the Canadian population.

Authors:  Nathalie Bastien; Diane Ward; Paul Van Caeseele; Ken Brandt; Spencer H S Lee; Gail McNabb; Brian Klisko; Edward Chan; Yan Li
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals.

Authors:  Junbao Yang; Eddie James; Michelle Roti; Laurie Huston; John A Gebe; William W Kwok
Journal:  Int Immunol       Date:  2008-12-02       Impact factor: 4.823

10.  Human metapneumovirus as a cause of community-acquired respiratory illness.

Authors:  Joanne Stockton; Iain Stephenson; Douglas Fleming; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.